Sign In
Buy CVALF
$1.55
-0.0200 (-1.27%)
At Close: Jun 02, 2026
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial Results
07:00am, Thursday, 14'th Aug 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2025 finan
Covalon Technologies Ltd. (CVALF) Q2 2025 Earnings Call Transcript
11:56am, Wednesday, 28'th May 2025
Covalon Technologies Ltd. (OTCQX:CVALF) Q2 2025 Earnings Conference Call May 28, 2025 8:30 AM ET Company Participants Brent Ashton - Chief Executive Officer Katie Martinovich - Interim Chief Financial
Covalon Reports Fifth Consecutive Quarter of Positive Earnings
07:00am, Wednesday, 28'th May 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 secon
Covalon Announces Exciting New Clinical Research Evaluating VALGuard® Vascular Access Line Guard
07:00am, Tuesday, 27'th May 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that exciting results
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2025 Financial Results
07:00am, Wednesday, 21'st May 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2025 finan
Covalon Retains Financial and Strategic Advisor to Advise on Shareholder Value-Enhancing Opportunities
07:00am, Tuesday, 20'th May 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it has engaged O
Covalon Announces Promotion of Kim Crooks to Chief Operating Officer and Appointment to Board of Directors
07:00am, Thursday, 15'th May 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce the promotion
Covalon to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, May 6, 2025
07:00am, Wednesday, 30'th Apr 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that it will be prese
Covalon to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025
07:00am, Thursday, 17'th Apr 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that they will be pre
Covalon Technologies Ltd. Poised for Strong Benefit From Positive US Tariff Outcome
09:06am, Thursday, 03'rd Apr 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company is pleased to announce the very positi
Covalon Announces Voting Results from Fiscal 2024 Annual Meeting of Shareholders
07:00am, Thursday, 20'th Mar 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced the results of the ma
Covalon Technologies Ltd. (CVALF) Q1 2025 Earnings Call Transcript
11:21am, Friday, 21'st Feb 2025
Covalon Technologies Ltd. (OTCQX:CVALF) Q1 2025 Earnings Conference Call February 21, 2025 8:30 AM ET Company Participants Brent Ashton - Chief Executive Officer Katie Martinovich - Interim Chief Fina
Covalon Reports Fourth Consecutive Quarter of Year over Year Revenue Growth and Positive Earnings
07:00am, Friday, 21'st Feb 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 first
Covalon Technologies Ltd. Named as a TSX Venture Exchange 2025 Top 50 Company
12:10pm, Wednesday, 19'th Feb 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, is pleased to announce that it has be
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2025 Financial Results
07:00am, Friday, 14'th Feb 2025
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2025 finan
